Discover where growth is breaking
Great healthcare companies get undervalued every day. One key reason: when growth doesn't translate into enterprise value, it's just risk in disguise.
Legacy DNA builds the commercial system that closes the gap between what your business is producing and what it's actually worth, before a diligence process makes that gap visible to everyone.
As seen in
THE BOOK
Eleven lessons from healthcare legends
Winning in Healthcare: How the Best Builders Turn Growth Into Enterprise Value is Dr. Roxie Mooney's new book sharing real healthcare growth stories, mapped to the six stages where enterprise value is either built or quietly lost.
A book about constructing enterprise value: how the best builders created organizations that buyers could understand, trust, and ultimately want to own.
Turn noise into negotiating power
Somewhere between activity and outcomes, the numbers stop telling the right story. Boards start asking harder questions. Sales cycles stretch longer than they should. Investors sense something before they can name it. And buyers, when the time comes, pay for what they can verify, not what they're told.
That enterprise value gap, between what's being built and what it's worth, is where most of the value is lost. This is the problem Legacy DNA is built to solve.
Speed
Rapid deliverables. Results in 90 to 120 days. A shorter runway to exit.
Clarity
Buyer-ready positioning, clear messaging, and market-ready narratives.
Impact
Proof-driven growth that converts into enterprise value.
THE SYSTEM
A closed-loop system designed to build enterprise value
The Enterprise Value Creation System™ is a proprietary framework that maps exactly where growth stalls, where alignment breaks, and where enterprise value is won or lost. Built from 20 years of work inside real healthcare companies at the moments that matter most.
Client growth story
Growth that compounds into valuation.
When BioPlus Specialty Pharmacy partnered with Legacy DNA, they were respected but overlooked in a crowded market. Their performance was real. The story didn't yet reflect the full value of what they'd built.
"Roxie didn't just observe from the edges. She helped us translate complexity into clarity and made sure the decisions we were making supported not just the next quarter, but what the company would be worth when it was time to hand it to someone else."
Mark Montgomery, Former CEO, BioPlus Specialty Pharmacy
Read the BioPlus growth story
WORK WITH US
The exit is won long before the process begins
Legacy DNA works with a small number of mid-market healthtech and pharmacy leaders each year, companies with $10M to $250M in revenue that are serious about enterprise value and what comes next.
A Strategic Fit Call is a 30-minute working session, not a pitch or demo. This practical conversation is about where growth is breaking and whether there's a fit to build the system together.